Andrew Helt (@CanEMDoc) header
Andrew Helt (@CanEMDoc) profile picture

Father & husband. Intensivist, ER doc, TTL, & POCUS proponent. Wilderness enthusiast.

London, Ontario
Joined November 2010
Photo by Andrew Helt (@CanEMDoc)Photo by Andrew Helt (@CanEMDoc)Photo by Andrew Helt (@CanEMDoc)Photo by Andrew Helt (@CanEMDoc)Photo by Andrew Helt (@CanEMDoc)Photo by Andrew Helt (@CanEMDoc)Photo by Andrew Helt (@CanEMDoc)Photo by Andrew Helt (@CanEMDoc)Photo by Andrew Helt (@CanEMDoc)Photo by Andrew Helt (@CanEMDoc)
Brilliant work! Congrats Dr. McKenzie and team!
Hot off the press in @CritCareMed! Check out our multidisciplinary approach to risk stratification + mgmt of resp failure in GBS and myasthenia. Thanks to @JAKrommMD, Dr Mobach @DCNSNeuro, @SolversonKevin, RRT Josh Waite + Dr Rabinstein @MayoClinicNeuro! @UCalgary @C3_ResNetwork
1
1
2
645
Andrew Helt retweeted
COPD - It did HAPPEN @JAMA_current:
6
78
1
291
46,734
Thank you to @CIHR_IRSC ACT competition for funding a Phase 3 trial of inhaled furosemide as supportive therapy for resp. failure 2nd to pulmonary infection. This adaptive international trial in 50 centers will enroll up to 1540 pts and run on the PRACTICAL platform.
2
3
1
19
2,131
after a week on service with lots of refractory shock, I added a section on refractory shock to IBCC. and also a section on hydroxocobalamin. better late than never 😬 any useful bits I left out? emcrit.org/ibcc/shock/
14
35
1
182
20,371
#CCR24 Day 3 Overview: DEFENDER: No benefit with SLG2Is for allcomers in ICU, but safe. REMAPCAP-steroid: Hard to make sense of this one, but no benefit to steroids in CAP. NAVIGATE: Early NIV prevents worsening of resp failure. REVISE: SUP with PPI ⬇️ GIBs @CritCareReviews
4
13
2,895
For the PO vs IV PPI (and H2 blocker vs PPI for that matter) PEPTIC (which was discussed at CCR in 2020) provides me some reassurance that the options for SUP are all similarly effective.
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
3
197
Andrew Helt retweeted
Presented at #CCR24: In a randomized trial involving patients undergoing invasive ventilation, pantoprazole decreased the risk of upper gastrointestinal bleeding as compared with placebo but did not affect mortality. Read the full REVISE trial results: nej.md/3KD01Xp
1
58
3
151
109,233
This might be the most insightful part of the entire trial. What matters to clinicians may not be what matters to our patients. Transfusion of a single unit, CT angio, and diagnostic endoscopy, all things that really matter to patients. #CCR24 #REVISEtrial
Kudos to the #REVISEtrial investigators for engaging patients and families to identify outcomes important to them #CCR24
3
6
1,915
Since @CritCareReviews and #CCR24 have had a couple of win ratio analyses, here’s a little plug for a video I made with @CMichaelGibson a few years back that is meant to be an accessible explainer of how it works. Please excuse my hair. It was a different time.
The Win Ratio is being used as the primary endpoint in many ongoing and upcoming randomized trials. @ADAlthousePhD and I demystify the Win Ratio in this short video clinicaltrialresults.org/dr-…
3
28
2
67
23,978
Amazing time at #CCR24!! Thanks again for making this doable for those of us with young children! First class! – at Belfast, Northern Ireland
2
1
1
26
6,808
2 related questions for @giovannilandoni & @GiacomoMonti re their #CCR24 #NAVIGATEtrial: 1) What was the role of RTs in managing the BiPap? Were they followed closely? Feature of the intervention or confounder? Certainly having an RT follow closely could change outcome. 1/2
2
1
3
620
2) Were any additional physicians more comminly involved if a patient was on NIV? In one hospital I work in, BiPap can occur in our telemetry unit with IM MRPs, but intensivist is often consulted to see. 2/2 #CCR24 #NAVIGATEtrial @CritCareReviews @GiacomoMonti @giovannilandoni
1
1
256
So, there was no RT involvement. TY for the answer & reposting of the slide! My question remains how much, compared to the usual care group, extra attention did the NIV group get from allied health & MDs? Looking forward to seeing the paper!!! #CCR24 #NAVIGATEtrial – at Belfast, Northern Ireland
1
2
310
The #NAVIGATEtrial shows a very impressive decrease in severe resp failure with WARD-BASED NIV. If findings external valid, then this could be BIG! #CCR24 I'm skeptical & still have Qs. Unsure my centre would replicate these results. Regardless, early NIV seems SAFE and SMART.
1
6
10
1,440
Is it possible that there are multiple miscoding errors? A double negative? The point estimate of benefit in CAPE-COD is not dissimilar to the risk of harm in REMAP-CAP. I assume not, but would be great to see the initial group randomised was similar to patients later on. #CCR24
1
260
All I can say is thank-you Steve Webb, Scott Berry & @ADAlthousePhD for going through @remap_cap's CAP steroid arm. Bayesian analysis alone are confusing... but adaptive platform design trials are mind-boggling at times... then the "unique" events in this domain... 🙃 #ccr24
2
316
Does #REMAPCAP end steroids for severe CAP's honeymoon period? There were some wild ups and downs in the trial, which accumulated in what on the surface appears to be harm from hydrocortisone, but at the very least showed no benefit. @remap_cap @CritCareReviews #CCR24
1
2
660